Download Say hello to the forerunner in lens replacement that`s proven and

Say goodbye to cataracts & astigmatism!
Say hello to the forerunner in lens
replacement that’s proven and reliable.
One simple solution to better vision.
Now, one simple procedure can help you
regain quality vision – while reducing dependence on eyeglasses or contact lenses.
If you have astigmatism, you probably rely on
eyeglasses or contact lenses to correct your vision.
The problem is, eyeglasses can be easily misplaced
or broken, and taking contact lenses in and out can
complicate an active, spontaneous lifestyle.
If you have been diagnosed with cataracts, one
simple outpatient procedure may eliminate your need
for eyeglasses or contact lenses -- replacing your
clouded cataract lens with an artificial lens designed
to correct astigmatism too. The solution is called the
STAAR Toric Intraocular Lens (or “IOL”), and it is the
first such lens to be approved by the FDA for its
effectiveness, safety and reliability.
What makes the STAAR Toric IOL such
a good choice?
The STAAR Toric IOL is a revolutionary, singlepiece foldable lens that your surgeon implants in
your eye during cataract surgery. It is specially
designed to correct astigmatism, and help you
regain quality vision. The STAAR Toric IOL is made
from a stable, non-toxic and flexible material the
eye comfortably welcomes, providing excellent
optical performance and high quality vision.
How the eye sees.
The eye is a complex organ composed of many
small parts, each vital to normal vision. The ability
to see clearly depends on how well these parts
work together.
Light rays reflected off objects enter the eye
through the cornea -- the transparent front part
of the eye that covers the iris and pupil.
Crystalline lens
Cornea
Pupil
Retina
Light ray
Vitreous
Iris
reaching the retina. The retina lines the back twothirds of the eye and is responsible for the wide
field of vision. For clear vision, light rays must focus
directly on the retina. When light focuses in front of
or behind the retina, the result is blurry vision.
What is a cataract?
The eye’s natural crystalline lens is the clear part of
the eye that helps focus incoming light rays on the
retina to form an image, which is then transmitted
to the brain through the optic nerve. The crystalline
lens is made primarily of water and protein, allowing
the structure to change shape to focus on near and
distant objects.
A cataract is a painless clouding of the eye’s lens.
Since a cataract affects the clarity of the lens, it
prohibits the light from passing through the lens
easily. This causes the retina to receive blurred or
distorted images. Because the brain cannot receive
clear images of objects, vision gradually becomes
Next, the light rays pass through an opening in
the iris (colored part of the eye), called the pupil.
The iris controls the amount of light entering the
eye by dilating or constricting the pupil. In bright
light, for example, the pupil contracts in order to
prevent too much light from entering. In dim light,
the pupil enlarges dramatically to allow more light
to enter the eye.
Light then reaches the crystalline lens. The lens
focuses light rays onto the retina by bending
(refracting) them. The cornea does most of the
refraction and the crystalline lens fine-tunes the
focus.
Behind the lens and in front of the retina is a
chamber called the vitreous body, which contains
a clear, gelatinous fluid called vitreous humor.
Light rays pass through the vitreous before
impaired. As a cataract progresses, the possibility
of cataract eye surgery should be strongly considered. As a cataract, if left untreated, could lead to
blindness. In fact, cataracts are the leading cause
of blindness in the world. Cataracts affect nearly
20.5 million Americans age 40 and older1.
What is “astigmatism?”
Astigmatism is a common condition that may
cause blurred vision. The distorted vision is due
to the eye’s cornea (corneal astigmatism) or lens
(lenticular astigmatism) having an irregular shape.
The cornea and lens of a perfectly shaped eye have
a smooth circular surface, like a sphere or round
ball. With astigmatism, the cornea or the lens will
have more of an oblong, football-like shape.
Blurred or distorted vision is typically experienced
Vision with cataract
and astigmatism.
Vision with cataract
corrected, astigmatism
remaining.
STAAR Toric
corrected vision.
by patients with moderate or high degrees of
astigmatism. These distortions can be corrected
through refractive surgery.
The STAAR Toric IOL: The single best
option for correcting cataracts and
astigmatism.
The surgery to remove cataracts is an outpatient
procedure, and involves replacing the clouded
natural lens with an artificial one. However, if you
also have astigmatism you may still experience
blurred or distorted vision, since the lens typically
implanted during ordinary cataract surgery cannot
correct this secondary condition.
Astigmatic patients who are planning cataract
surgery can request the use of a STAAR Toric
IOL during their lens replacement – treating
the
cataractpatients
and thewho
astigmatism
at the
same
Astigmatic
are planning
cataract
time.
Thecan
STAAR
Toric
ideal
for cataract
cataract
Astigmatic
patients
who
areisplanning
surgery
request
theIOL
use
of
a STAAR
Toric
patients
with
regular,
pre-existing
astigmatism.
surgery
can
request
use of a STAAR
Toric
IOL during
their
lens the
replacement
– treating
It
has
beentheir
used
safely
and effectively
a
IOL
during
replacement
– treating
the
cataract
andlens
the
astigmatism
at
theinsame
countless
number
of astigmatism
procedures.
the
cataract
and the
same
time.
The STAAR
Toric
IOL is idealat
forthe
cataract
time.
Thewith
STAAR
Toricpre-existing
IOL is idealastigmatism.
for cataract
patients
regular,
patients
withused
regular,
pre-existing
astigmatism.
It has been
safely
and effectively
in a
Open
your
eyes
to
quality
vision
today.
It
has beennumber
used safely
and effectively in a
countless
of procedures.
countless
number
procedures.
The
STAAR Toric
IOL of
may
be the single best solution
for providing quality vision to patients with cataracts
Open
your eyesIt to
quality
vision
today.
and astigmatism.
is the
first such
lens
to be
Open
your
eyes
to
quality
vision
today.
approved by the FDA for its effectiveness, safety
The STAAR Toric IOL may be the single best solution
and
reliability.
The
STAAR Toric
IOLvision
may be
singlewith
bestcataracts
solution
for providing
quality
to the
patients
Ifand
you
have a quality
cataract,
askfirst
your
doctor
ifto
the
for
providing
to
patients
with
cataracts
astigmatism.
It isvision
the
such
lens
be
STAAR
Toric
help
you eliminate
your
and
astigmatism.
It isalso
theits
first
such
lens to safety
be
approved
by IOL
the can
FDA
for
effectiveness,
astigmatism,
allowing
youitstoeffectiveness,
recapture quality
vision
approved
by the
FDA for
safety
and reliability.
– and
a hassle-free, spontaneous lifestyle.
and
reliability.
If you have a cataract, ask your doctor if the
IfSTAAR
you have
cataract,
askhelp
youryou
doctor
if theyour
Torica IOL
can also
eliminate
References Toric IOL
STAAR
can also
you eliminate
your
astigmatism,
allowing
youhelp
to recapture
quality
vision
1. National Eye Institute. Prevalence of Adult Vision Impairment and Age-Related Eye Disease
astigmatism,
allowing
recapture
quality vision
in America
Problems
in the spontaneous
U.S.you
2002;to
22-24
– and
a Vision
hassle-free,
lifestyle.
– and a hassle-free, spontaneous lifestyle.
References
1. National Eye Institute. Prevalence of Adult Vision Impairment and Age-Related Eye Disease
References
in America Vision Problems in the U.S. 2002; 22-24
1. National Eye Institute. Prevalence of Adult Vision Impairment and Age-Related Eye Disease
in America Vision Problems in the U.S. 2002; 22-24
One simple solution to better vision.
One simple solution to better vision.
One simple solution to better vision.
STAAR® Surgical Company
Vision of the future
1911 Walker Ave.
Monrovia, CA 91016
(800) 352-7842
www.staar.com
©2013 STAAR Surgical Company
10-0007-51 A
®
®
STAAR
Surgical
Hauptstrasse
104Company
Vision
of
the
future
CH
2560
Nidau/Switzerland
STAAR® Surgical Company
191132
Walker
Ave.
+41
332 8888
Vision of the future
Monrovia, CA 91016
1911 Walker Ave.
(800) 352-7842
Monrovia, CA 91016
(800) 352-7842
TheClearChoice.
An exceptional balance of stability and predictability:
Predictable visual outcomes, stable design, and
optical quality in everything you see.
Stable. Predictable. Precise.
Rotational stability, predictable outcomes,
in a balanced astigmatic cataract solution.
Single-piece design
provides dual-direction
positioning.
Microetched haptic
designed to promote
bioadhesion. .
S T A B I L I T Y
Large foramina promote
development of fibrous adhesions
to enhance fixation and stability.1
Longer length haptic aids in
rotational stability.2
Delivering predictable high
quality vision that has
patients saying “wow”
Available in a range of spherical
powers with cylindrical adds of 2.0 D
and 3.5 D
P R E D I C T A B I L I T Y
STAAR Silicone lens technology
induces fewer higher order aberrations
than acrylic lenses3
I
T0
T1
R1
R2
T3
Lower refractive index (RI) when
compared to acrylic lenses – minimizing
incidence of halos, glare, and ghosting
Exceptional Clarity
• STAAR Toric IOL demonstrates comparable if not greater visual
acuity with stable and predictable outcomes as compared to other
competitive toric lenses
Exceptional Visual Acuity4
POST-OP UCVA AT 1 MOnTh
UCVA CUMULATIVe PeRCenT Of eyeS
97%
91%
81%
72%
57%
62%
26%
19%
20/20 or Better
20/25 or Better
AcrySof® Toric IOL (n=47)
20/30 or Better
20/40 or Better
STAAR Toric IOL (n=34)
Stable and Predictable Outcomes4
PRedICTABILITy Of CyLIndeR CORReCTIOn
PeRCenTAge Of eyeS wITh POST-OP MAnIfeST RefRACTIOn CyLIndeR
wIThIn 0.5 d And 1.00 d Of TARgeT
98% 100%
86% 86%
+/- 0.5 D
AcrySof® Toric IOL (n=47)
Data courtesy of Dr. Ken Maverick, Dallas, Texas”
+/- 1.0 D
STAAR Toric IOL (n=29)
• STAAR silicone lens technology produces significantly fewer optical
aberrations than do acrylic lenses3
Higher Order Aberrations Study3
COMPARISOn Of hIgheR ORdeR ABeRRATIOnS,
SILICOne IndUCed feweR ABeRRATIOnS ThAn ACRyLIC
1.28
Pre-Op
0.32
Post-Op
0.31
0.93
Silicone
AA4204Vf
n=24
Acrylic
Alcon SA60
n=16
• STAAR silicone lenses feature a lower refractive index (RI) when
I
compared to acrylic lenses – minimizing incidence of halos, glare,
T0
T1
R1
and ghosting
o Light is efficiently transmitted through the silicone lens
R2
T3
but commonly reflected through an acrylic lens
RI Can Make A Difference In Functional Vision
With Night Driving And In The Living Room**
Silicone
Index of refraction 1.41
no visible glare, halos or
ghosting
Acrylic
Index of refraction 1.55
Serious glare, halos and
ghosting
*All images depict reflections 10º from line of sight.
Rotational Stability Design Improvements
Microetched grip
• Microetched haptics and large diameter foramina promote
bioadhesion
• Optimizes capsular bag stability for an exceptional fit
Available enhanced horizontal axis IOL (11.2 mm)
• greater prevention of lens rotation in nearsighted eyes2
Large foramina
• Allow fibrocellular tissue to migrate through and around the lens
foramina to secure the lens to the equator of the capsular bag
for added stability.1
“fibrous adhesions often occur between the anterior and posterior
capsules following ingrowth of fibrocellular tissue through the holes.
This helps enhance the fixation and stability of these designs within
the capsular bag.”1
david Apple, Md, Charleston, South Carolina
Single-piece design
• Simplified delivery and controlled placement in dual-directional positioning
• highly resistant to rotation compared to C-loop haptic lenses5
• Minimal rate of lens repositioning – and fewer returns to the
ophthalmologist2,6,7
Lens Stability That Requires Minimal Repositioning
Toric Repositioning Rates2,5,6
STAAR Toric TL
2/130
1.5%
AcrySof® Toric
3/263
1.1%
“STAAR Toric IOL is my ‘go to’ lens for astigmatism correction. Both in
terms of its first-rate clinical performance and my practice’s bottom line,
the STAAR Toric IOL takes care of business.”
Andrew Siedlecki, Md, Amherst, ny
“I have been using the STAAR Toric IOL to treat astigmatism for over a
decade and and my experience is that it has excellent rotational stability and
the refractive outcomes have allowed an increased freedom from glasses for
my patients”
Robert J. weinstock, Md, eye Institute of west florida
The Clear Choice in
Stability and Predictability
A 1-2 Combination Knockout Punch in Astigmatic Cataract Surgery.
Stable. Predictable. Precise.
For more information, please visit www.staar.com or call STAAR Customer
Service at 800-352-7842.
References
Important Safety Information for STAAR Toric IOL
1. Apple dJ, werner L. experts share insights
on IOL choice ; The best design is yet to
come, Ocular Surgery News. 2002.
INDICATIONS: The Silicone 1P Toric IOLs are intended to improve uncorrected visual acuity, correct aphakia and decrease refractive
cylinder resulting from corneal astigmatism in persons aged 60 and over. The device is to be implanted into the capsular bag through
a tear-free capsulorhexis (circular tear anterior capsulotomy). The 2.0 D Toric IOL is intended for patients having 1.5 D to 2.25 D
of pre-existing corneal cylinder while the 3.5 D Toric IOL is intended for patients having greater than 2.25 D of pre-existing corneal
cylinder. PRECAUTIONS: 1. The potential for the IOL to rotate causing misalignments that will reduce the effectiveness of the Toric IOL
may be greater in larger-than-average eyes. 2. IOL rotation less than 30° may not warrant reorientation. 3. Any reorientations should
be performed prior to IOL fixation, generally within the first 2 weeks. 4. Silicone 1P Toric IOL is for Single use. Do not resterilize this
intraocular lens by any method as this can produce undesirable side effects. 5. Do not store IOLs at temperatures over 115° Fahrenheit.
6. Use only sterile intraocular irrigating solutions (e.g., balanced salt or normal saline solution) to rinse and/or soak lenses. 7. A high
level of Surgical skill is required for intraocular lens implantation. A surgeon should have observed and/or assisted on numerous
surgical implantations, and successfully completed one or more courses on intraocular lens implantation before attempting to implant
intraocular lenses.
2. Chang df. early Rotational Stability of the
Longer Staar Toric Intraocular Lens: fifty
Consecutive Cases. J Cataract Refract
Surg. 2003;29:935-939.
3. Martin Rg, Sanders dR. A comparison
of higher order aberrations following implantation of four foldable intraocular lens
designs. J Refract Surg. 2005;21:716-721.
4. data on file, STAAR Surgical.
5. Alio, J. L., et al. (2013) Clinical and optical
intraocular performance of rotationally
asymmetric multifocal IOL plate-haptic design versus C-loop haptic design; Journal
of Refractive Surgery, 29(4); 252-59.
6. david Chang, Md. Comparing the STAAR
and AcrySof Toric IOLs. Cataract & Refractive Surgery Today. May 2007.
7. david Chang, Md. Repositioning
Technique and Rate for Toric Intraocular
Lenses. Journal of Cataract and Refractive
Surgery. July 2009.
STAAR® Surgical Company
Vision of the future
1911 walker Ave.
Monrovia, CA 91016
(800) 352-7842
staar.com
©2013 STAAR Surgical Company
10-0007-50 A
WARNINGS: 1. This IOL should not be implanted if the posterior capsule is ruptured or if a primary capsulotomy is to be performed.
2. Before implantation of a Toric IOL in the fellow eye, surgeons should verify that the Toric IOL in the first eye is properly aligned. 3.
Rotation of toric IOLs away from their intended axis can reduce their effectiveness. Misalignment of greater than 30° - 40° will increase
postoperative refractive cylinder. Repositioning of this IOL to the intended axis should only be performed when a significant reduction
in effectiveness of the Toric IOL is noticed. This IOL should only be repositioned when the refractive needs of the patient outweigh the
potential risks inherent in any surgical reintervention into the eye. 4. YAG-Laser posterior capsulotomies should be delayed until at least
12 weeks after the implant surgery. The posterior capsulotomy opening should be kept as small as possible. There is an increased risk
of IOL dislocation and/or secondary surgical reintervention with early or large capsulotomies. 5. As with any surgical procedure, there
is risk involved. Potential complications accompanying cataract or implant surgery may include, but are not limited to, the following:
corneal endothelial damage, nonpigment precipitates, cystoid macular edema, infection, retinal detachment, vitreous loss, pupillary
block, secondary glaucoma, iris prolapse, vitreous wick syndrome, pupillary membrane, corneal endothelial dystrophy, glaucoma, active
chronic anterior or posterior uveitis, rubeosis iritis, synechiae, short anterior segment. 6. Some adverse reactions which have been associated with the implantation of intraocular lenses are: hypopyon, intraocular infection and acute corneal decompensation. Secondary
surgical interventions include: IOL repositioning, IOL removal due to corneal touch, IOL removal due to inflammation, corneal transplant,
IOL replacement, vitreous aspiration for pupillary block, iridectomy for pupillary block. 7. The safety of intraocular lens implantation has
not been substantiated in patients with pre-existing ocular conditions (e.g., chronic drug miosis, glaucoma, amblyopia, diabetic retinopathy, previous corneal transplant, history of retinal detachment, or iritis). Physicians considering IOL implantation in such patients
should explore the use of alternative methods of aphakic correction and consider IOL implantation only if alternatives are deemed
unsatisfactory to meet the needs of the patient. 8. The long-term effects of intraocular lens implantation have not been determined.
Therefore, physicians should continue to monitor implant patients postoperatively on a regular basis. 9. Physicians considering IOL
implantation in patients with senile macular or retinal degeneration should be aware that the patient may not achieve any improvement
in central visual acuity following intraocular lens implantation. 10.Patients with ocular pathology, (e.g., glaucoma or corneal diseases),
may not achieve the visual acuity of patients without such problems. 11.Secondary glaucoma has been reported occasionally in patients
with controlled glaucoma who received lens implants. The intraocular pressure of implant patients with glaucoma should be carefully
monitored postoperatively. 12.The need for a secondary iridectomy for pupillary block may be prevented by one or more iridectomies
at the time of IOL implantation. 13.The safety and effectiveness of this IOL if placed in the anterior chamber have not been established.
Implantation of posterior chamber lenses in the anterior chamber has been shown in some cases to be unsafe. Such implantation
should take place only under an investigational protocol approved by FDA. 14.The effectiveness of UV-absorbing IOLs in reducing the
incidence of retinal disorders has not been established. 15.This IOL is not intended, nor should it be used, for a clear lens exchange.
16.Special consideration should be given to the dimensions of IOLs at the extreme ends of the power range in relation to the anatomical
clearances in the patient’s eye. The potential impact of factors such as optic central thickness, optic edge thickness, and overall lens
size on the patient’s long term clinical outcome must be carefully weighed against the potential benefit associated with the implantation
of an intraocular lens. The patient’s clinical progress should be carefully monitored. 17.Since clinical studies was conducted with the
IOL being implanted in the capsular bag only, there are insufficient clinical data to demonstrate its safety and efficacy for placement in
the ciliary sulcus. 18.Physicians considering IOL implantation under any of the following circumstances should weigh the potential risk/
benefit ratio: a. Recurrent anterior or posterior segment inflammation or uveitis. b. Patients in whom the intraocular lens may affect the
ability to observe, diagnose or treat posterior segment diseases. c. Surgical difficulties at the time of cataract extraction which might
increase the potential for complications (e.g., persistent bleeding, significant iris damage, uncontrolled positive pressure, or significant
vitreous prolapse or loss). d. A distorted eye due to previous trauma or developmental defect in which appropriate support of the IOL is
not possible. e. Circumstances that would result in damage to the endothelium during implantation. f. Suspected microbial infection. g.
Children under the age of 18 years are not suitable candidates for intraocular lenses. 19.Patients in whom neither the posterior capsule
nor zonules are intact enough to provide support. 20.This IOL should not be implanted if the posterior capsule is ruptured or if a primary capsulotomy is to be performed. 21.YAG-Laser posterior capsulotomies should be delayed until at least 12 weeks after the implant
surgery. The posterior capsulotomy opening should be kept as small as possible. There is an increased risk of lens dislocation and/or
secondary surgical reinterventions with early or large capsulotomies.
ATTENTION: Reference the Directions for Use labeling for a complete
listing of adverse events which may include iritis and corneal edema.
Surgical Guide
Stable. Predictable.
Precise. power: visit staartoric.com to calculate IOL powers and lens orientation
• Spherrical
Position Toric IOL to Steep Corneal Meridian
95º
90º
Cylinder power selected according to corneal astigmatism nomogram as follows:
Position Toric IOL to Steep Corneal Meridian180º
0º
95º 90º
With the Rule1
Corneal Astigmatism
IOL Cylinder Power
Expected Cylinder Correction from IOL2
• Spherrical power: visit staartoric.com to calculate IOL powers and lens orientation
1.5 D to 2.25 D
2.0 D
1.5 D
2.5 D to 3.0 D
3.5 D
2.25 D
3.25 D or more3
3.5 D+ LRIs
2.25 D
Against
the Rule1
Corneal Astigmatism
IOL Cylinder Power
Expected Cylinder Correction from IOL2
1.5 D to 2.25 D
2.0 D
1.5 D
2.5 D to 3.0 D
3.5 D
2.25 D
1.25 D to 1.75 D
3.5 D+
2.0
D LRIs
2.25D D
1.5
2.0 D to 2.5 D
3.5 D
2.25 D
1.25 D to 1.75 D3
2.75
D or more
2.0 D
3.5 D+ LRIs
1.5 D
2.0 D to 2.5 D
3.5 D
2.25 D
180º
0º
Cylinder power selected according to corneal astigmatism nomogram as follows:
With the Rule1
Corneal Astigmatism
3.25 D or more3
Against the Rule1
IOL Cylinder Power
Expected Cylinder Correction from IOL2
Expected Cylinder Correction from IOL
• Spherrical power: visit staartoric.com to calculate IOL powers
and lens orientation
Corneal Astigmatism
IOL Cylinder Power
2
2.25 D
3.5 D+ LRIs
2.25 D
2.75 D or more
nomogram
assumes astigmatically neutral
surgery.
1
With the Rule,
steep astigmatically
corneal meridian
between
46 to 134; Against the Rule, steep corneal
nomogram
assumes
neutral
surgery.
With the Rule, steep corneal meridian between 46 to 134; Against the Rule, steep corneal
meridian between 0 to 45 and 135 to 180.
meridian between 0 to 45 and 135 to 180.
power
selected
according
to corneal
astigmatism nomogram as follows:
2Cylinder
Approximate
Approximate value
value ofof the
the equivalent
equivalent IOL
IOL cylinder
cylinder power
power atat the
the cornea.
cornea.
Combine with Astigmatic keratotomy or Limbal Relaxing Incisions.
3
Combine with Astigmatic keratotomy or Limbal Relaxing Incisions.
3
1
2
3
Available in a range of spherical powers with cylindrical adds of 2.0 D and 3.5 D
With the Rule
Available
in a range of spherical powers with cylindrical adds of 2.0 D and 3.5 D
1 plane, the optics of the 2.0 D and 3.5 D lenses correct
• At the corneal
1.4 D and 2.3 D of astigmatism, respectively
•Corneal
At theAstigmatism
corneal plane, the optics
of the Power
2.0 D and 3.5 D lenses
IOL Cylinder
Expectedcorrect
Cylinder Correction from IOL2
1.4 D and 2.3 D of astigmatism, respectively
1.5 D to 2.25 D
2.0 D
1.5 D
2.5 D to 3.0 D
3.5 D
2.25 D
3.25 D or more3
3.5 D+ LRIs
2.25 D
The STAAR Toric IOL with advanced
to:
noitatneiro silicone
snel dna srewop Llens
OI etalucltechnology
ac ot moc.cirotraats tisiv :ris
ewodesigned
p lacirrehpS •
• Produce significantly fewer optical aberrations than acrylic lenses1
naidireM laenroC peetS ot LOI ciroT noitisoP
• Demonstrates comparable if not better visual acuity with stable and predictable outcomes as
º09
º59
compared to the other competitive toric lenses2
:swollof sa marg•oProduce
mon mslower
itamgincidence
itsa laenrofochalos,
ot gnglare
idrocand
ca dglistenings
etceles rebecause
wop redofnilayClower refractive index of
silicone lenses compared to acrylic lenses1
naidireM laenroC peetS ot LOI ciroT noitisoP
º0
º081
Prevalence of Astigmatism in the US Population
1
º09 º59
2
eluR eht htiW
30%
LOI morf noitcerroC rednilyC detcepxE
31%
rewoP rednilyC LOI
msitamgitsA laenroC
1.5 D to 3.5 D = 20%
19%
noitatneiro snel dna srewop LOI eta
luclac ot moc.cirotraats tisiv :rewop lacirrehpS •
D 5.1
D 0.2
D 52.2
10%
D 5.32%
D 52.2 ot D 5.1
D 0.3 ot D 5.2
º0
º081
:swollof sa margomon msitamgitsa laenroc ot gnidrocca detceles rewop rednilyC
D 502.2
5%
0.5
1.0
1.5
sIRL2.0+D 5.32.5
1%
1%
3.0
3.5
0%
3
0%
erom4.0ro D 4.5
52.3
0%
5.0
SOuRCe: COmPRehenSIve RePORT On The GLObAL IOL mARkeT by mARkeT SCOPe (mAy 2012)
2
LOI morf noitcerroC rednilyC detcepxE
2
LOI morf noitcerroCRotational
rednilyC detcepxE
D 5.1
D 52.2
rewoP rednilyC LOI
1
eluR eht htiW
1
msitamgitsA laenroC
Stability
rewoP rednilyC LOI
msitamgitsA laenroC
D 0.2
D 5.3
eluR eht tsniagA
D 52.2 ot D 5.1
D 0.3 ot D 5.2
D 5mm
.1 length aids in preventing
D 0.2 IOL rotation Dfor57larger
.1 ot D 5myopic
2.1
Overall 11.2
eyes
D 52.2
sIRL +D 5.3
3
1
2
D 52.2
D 5.3
erom ro D 52.3
eluR eht tsniagA
D 5.2 ot D 0.2
noitatneiro snel dna srewop LOI etaluclac ot moc.cirotraats tisiv :rewop lacirrehpS •
LOI morf noitcerroC rednilyC detcepxE
rewoP rednilyC LOI
msitamgitsA laenroC
D D525..21
sIRL +DD 05..23
3D 57.1 ot D 52.1
D 52.2
D 5.3
D 52.2
erom ro D 57.2
D 5.2 ot D 0.2
.ysrIeRgLru+sDla5rt.u3en yllacitamgitsa semeurosm
sa rmoaDrgo5m7.o2n
laenroc peets ,eluR eht tsniagA ;431 ot 6.y4rengerueswltaerbtuneanidyilrleam
egnirtosca pseem
etsus,sealuRmaerhgtohmtioWn1
citalam
• Promotes greater bioadhesion for capsular bag stability
laenroc peets ,eluR eht tsniagA ;431 ot 64 neewteb naidirem laenroc peets ,eluR eht htiW
.081 ot 531 dna 54 ot 0 neewteb naidirem
:swollof sa margLarge
omonforamina
msitamg..iaateesnnarroolccaeeehhntt rttaaorrceewwoootpp grreenddinndiillyyr.cco08LLc1OOcIIoatttnn5eed3llaae1vvtiiduucqqneaeele5eehh4sttoffroote0eewuunlleoaaevvpweetttreaaebmmdniixxnaooidrrippliyrppeCAAm2
.snoisicnI gnixaleR labmiL ro ymototarek citamgitsA htiw enibmoC
• Large foramina
.snoisicnallow
I gnixalefibrocellular
R labmiL ro ymtissue
ototarektocimigrate
tamgitsA hthrough
tiw enibmoand
C3 around the lens hole
3
Microetched haptics
1
2
3
D 5.3 dna D 0.2 fotosdlock
da lathe
cirdlens
nilyctohtthe
iw sequator
rewop laofcirthe
ehpcapsular
s fo egnabag
r a nfor
i eladded
baliavAstability
3
“Fibrous adhesions often occur between the anterior and posterior capsules following
citpo eht ,enalp lae1nroc eht tA •
ivWA
D 5.3 dnatcDerr0o.c2 singrowth
foessndedl aDla5ofc.3irfibrocellular
ddnnilaycDh0ti.w2 setissue
rhetwfoopsthrough
lacirehpthe
s foholes.
egnarThis
aelunRihelps
eelbhtahliatenhance
the fixation and
ylevitcepser ,msitamgitsa fo D 3.2 dna D 4.1
stability of these designs within the capsular bag.” Dr. David Apple 3
2
l D 5.3 dna Drew0o.2P erehdtnfiolyCsLcOitpI o eht ,enalmpsliataemngriotscAelahetntrAoC•
LOI morf noitcerroC rSingle-piece
etdcneilyrrCodcestceespnxEedesign
ylevitcepser ,msitamgitsa fo D 3.2 dna D 4.1
• Simplified delivery and controlled placement with dual-directional positioning
D 5.1
D 0.2
D 52.2 ot D 5.1
• Resists rotation as compared to C-loop lens design4
D 52.2
D 5.3
D 52.2
sIRL +D 5.3
D 0.3 ot D 5.2
3
erom ro D 52.3
•Surgical
Spherrical power:Pearls
visit staartoric.com to calculate IOL powers and lens orientation
Toric
IOL to
Corneal
•Position
Patient axis
should
beSteep
marked
pre-op Meridian
at the slit lamp, and sitting upright
• CCC should be no larger than 5.5 mm in diameter
95º
90º
Cylinder power selected according to corneal astigmatism nomogram as follows:
• minimize bSS infusion of the anterior segment. Leave eye relatively and safely soft to prevent IOL
movement.
eye somewhat
“softer” than usual most likely allows the capsular bag to
Position
ToricLeaving
IOL totheSteep
Corneal Meridian
180º
0º
collapse around the IOL more immediately
95º 90º
Rule viscoelastic. Compared to dispersive viscoelastics, these are less likely to coat
•With
usethe
a cohesive
1
the IOL surface
Astigmatism
IOLbehind
Cylinderthe
Power
Expected CylindertoCorrection
IOL
•Corneal
Remove
viscoelastic trapped
IOL with irrigation-aspiration
maximizefrom
posterior
2
capsule-IOL surface contact
• Spherrical power: visit staartoric.com to calculate IOL powers and lens orientation
1.5 D to 2.25 D
2.0 D
2.5 D to 3.0 D
3.5 D
1.5 D
• Confirm lens orientation after I&A and after wound closure to ensure that Toric IOL did not move
180º
2.25 D
0º
• yAG-Laser posterior capsulotomies should be delayed until at least 12 weeks after the implant
Cylinder
selected
accordingopening
to corneal
astigmatism
nomogram
as follows:
surgery. power
The posterior
capsulotomy
should
be kept as small
as possible.
There is an
3
3.25
D or more
3.5 D+and/or
LRIs secondary surgical
2.25reintervention
D
increased
risk of IOL dislocation
with early or large
capsulotomies
With
the Rule1
1
2
Astigmatism should beIOL
Cylinder Power
Expected
Cylinderwithin
Correction
from2IOL
•Corneal
Any reorientations
performed
prior to IOL fixation,
generally
the first
weeks
Against the Rule
1.5 D to 2.25 D
2.0 D
1.5 D
2.5 D to 3.0 D
3.5 D
2.25 D
1.25 D to 1.75 D
3.5 D+
2.0
D LRIs
2.25D D
1.5
2.0 D to 2.5 D
3.5 D
2.25 D
1.25 D to 1.75 D3
2.75
D or more
2.0 D
3.5 D+ LRIs
1.5 D
2.0 D to 2.5 D
3.5 D
2.25 D
Corneal Astigmatism
3.25 D or more3
Against the Rule1
IOL Cylinder Power
Expected Cylinder Correction from IOL2
Expected Cylinder Correction from IOL
• Spherrical power: visit staartoric.com to calculate IOL powers
and lens orientation
Corneal Astigmatism
IOL Cylinder Power
2
2.25 D
3.5 D+ LRIs
2.25 D
2.75 D or more
nomogram
assumes astigmatically neutral
surgery.
1
With the Rule,
steep astigmatically
corneal meridian
between
46 to 134; Against the Rule, steep corneal
nomogram
assumes
neutral
surgery.
With the Rule, steep corneal meridian between 46 to 134; Against the Rule, steep corneal
meridian between 0 to 45 and 135 to 180.
meridian between 0 to 45 and 135 to 180.
power
selected
according
to corneal
astigmatism nomogram as follows:
2Cylinder
Approximate
Approximate value
value ofof the
the equivalent
equivalent IOL
IOL cylinder
cylinder power
power atat the
the cornea.
cornea.
Combine with Astigmatic keratotomy or Limbal Relaxing Incisions.
3
Combine with Astigmatic keratotomy or Limbal Relaxing Incisions.
3
1
2
3
Available in a range of spherical powers with cylindrical adds of 2.0 D and 3.5 D
With the Rule
Available
in a range of spherical powers with cylindrical adds of 2.0 D and 3.5 D
1 plane, the optics of the 2.0 D and 3.5 D lenses correct
• At the corneal
1.4 D and 2.3 D of astigmatism, respectively
•Corneal
At theAstigmatism
corneal plane, the optics
of the Power
2.0 D and 3.5 D lenses
IOL Cylinder
Expectedcorrect
Cylinder Correction from IOL2
1.4 D and 2.3 D of astigmatism, respectively
1.5 D to 2.25 D
2.0 D
1.5 D
2.5 D to 3.0 D
3.5 D
2.25 D
3.25 D or more3
3.5 D+ LRIs
2.25 D
STAAR
noitatneToric
iro snel dna IOL
srewop LCalculator
OI etaluclac ot moc.cirotraats tisiv :rewop lacirrehpS •
aidireM laenroC peetS ot LOI ciroT noitisoP
PreVize Optimized Toric IOL calculationnsoftware
º09
º59
:swollof sa margomon msitamgitsa laenroc ot gnidrocca detceles rewop rednilyC
naidireM laenroC peetS ot LOI ciroT noitisoP
º0
º081
º09 º59
2
LOI morf noitcerroC rednilyC detcepxE
eluR eht htiW
1
rewoP rednilyC LOI
msitamgitsA laenroC
noitatneiro snel dna srewop LOI etaluclac ot moc.cirotraats tisiv :rewop lacirrehpS •
D 5.1
D 0.2
D 52.2 ot D 5.1
D 52.2
D 5.3
D 0.3 ot D 5.2
D 52.2
sIRL +D 5.3
º0
º081
:swollof sa margomon msitamgitsa laenroc ot gnidrocca detceles rewop rednilyC
•2LCreates
OI morf na
oitsurgical
cerroC redworksheet
nilyC detcepthat
xE includes preoperative
rewoP rednilyCdata
LOI
3
erom ro D 52.3
1
eluR eht htiW
1
msitamgitsA laenroC
eluR eht tsniagA
D 5.1
D 0.2
•2 List of suggested surgical powers
(The choice of the lens
selection is yours) D 52.2 ot D 5.1
LOI morf noitcerroC rednilyC detcepxE
D 52.2
rewoP rednilyC LOI
D 5.3
msitamgitsA laenroC
• Clearly labeled illustration of the exact placement of the STAAR Toric IOL
D 5.1
D 52.2
D 0.2
sIRL +D 5.3
D 0.3 ot D 5.2
Der5o7m.1root DD 5522..31
3
• To ensure that the power of the cylindrical correction is maximized, use the
two markings indicat1
eluR eht tsniagA
ing the axis of the cylindrical correction of the lens and align them with the steep corneal meridian
2
D 52.2
D 5.3
D 5.2 ot D 0.2
noitatneiro snel dna srewop LOI etaluclac ot moc.cirotraats tisiv :rewop lacirrehpS •
LOI morf noitcerroC rednilyC detcepxE
D D525..21
D 52.2
rewoP rednilyC LOI
msitamgitsA laenroC
3D 57.1 otrequired
sIRSTAAR
L +DD 05..23 Toric IOL calculator
erom ro DD 5572..21 data
D 5.3
D 5.2 ot D 0.2
• Steep k reading
D 52.2
.ysrIeRgLru+sDla5rt.u3en yllacitamgitsa semeurosm
sa rmoaDrgo5m7.o2n
• Steep k meridian/axis
laenroc peets ,eluR eht tsniagA ;431 ot 6.y4rengerueswltaerbtuneanidyilrleam
egnirtosca pseem
etsus,sealuRmaerhgtohmtioWn1
citalam
laenroc peets ,eluR eht tsniagA ;431 ot 64 n•eeFlat
wtebk
..008811nooareading
ttid55ir33e11mddlnnaaaen55r44ocoottpe00enntseeee,ewwlutteeRbbennhaatiiddhiitrrieeWm
:swollof sa margomon msitamg..iaateesnnarroolccaeeehhntt rttaaorrceewwoootpp grreenddinndiillyyrccoLLcOOcIIattnneedllaaevvtiiuucqqeeeleeehhstt ffrooeeewuulloaavvpeettraaemmdiixxnoorripplyppCAAm2
• Flat k meridian/axis
.snoisicnI gnixaleR labmiL ro ymototarek citamgitsA htiw enibmoC
.snoisicnI gnixaleR labmiL ro ymototarek citamgitsA htiw enibmoC3
3
1
2
3
• Surgically induced astigmatism
D 5.3 dna D 0.2 fo sdda lacirdnilyc htiw srewop lacirehps fo egnar a ni elbaliavA
(SIA) estimate
tcerroc sesnel D 5.3 dna D 0.2 eht fo scitpo eht ,enalp lae1nroc eht tA •
ylevitceps•erIncision
,msitamsite
gitsa fo D 3.2 dna D 4.1
D 5.3 dna D 0.2 fo sdda lacirdnilyc htiw srewop lacirehps fo egnar aelunRi eelbhtahliativWA
2
fiolyCsLcOitpI o eht ,enalmpsliataemngriotscAelahetntrAoC•
LOI morf noitcerroC retdcneilyrrCodcestceespnxEel D 5.3 dna Drew0o.2P erehdtnwww.staartoric.com
ylevitcepser ,msitamgitsa fo D 3.2 dna D 4.1
D 5.1
D 0.2
D 52.2 ot D 5.1
D 52.2
D 5.3
D 52.2
sIRL +D 5.3
D 0.3 ot D 5.2
3
erom ro D 52.3
• Spherrical power: visit staartoric.com to calculate IOL powers and lens orientation
Position
PositionToric
ToricIOL
IOLtotoSteep
SteepCorneal
CornealMeridian
Meridian
95º
95º 90º
90º
Cylinder power selected according to corneal astigmatism nomogram as follows:
Position Toric IOL to Steep Corneal Meridian
180º
180º
0º0º
95º 90º
With the Rule1
Corneal Astigmatism
IOL Cylinder Power
Expected Cylinder Correction from IOL2
• •Spherrical
Spherricalpower:
power:visit
visitstaartoric.com
staartoric.comtotocalculate
calculateIOL
IOLpowers
powersand
andlens
lensorientation
orientation
1.5 D to 2.25 D
2.0 D
1.5 D
2.5 D to 3.0 D
3.5 D
2.25 D
3.25 D or more3
3.5 D+ LRIs
2.25 D
180ºastigmatismnomogram
0º
Cylinder
Cylinderpower
powerselected
selectedaccording
accordingtotocorneal
cornealastigmatism
nomogramas
asfollows:
follows:
1 1
With
Withthe
theRule
Rule
Against the Rule
1
Corneal
CornealAstigmatism
Astigmatism
IOL
IOLCylinder
CylinderPower
Power
2 2
Expected
ExpectedCylinder
CylinderCorrection
Correctionfrom
fromIOL
IOL
1.51.5DDtoto2.25
2.25DD
2.0
2.0DD
1.51.5DD
2.5
2.5DDtoto3.0
3.0DD
3.5
3.5DD
2.25
2.25DD
2.0 D
2.25
2.25DD
Corneal Astigmatism
1.25 D to 1.75 D
3 3
3.25
3.25DDorormore
more
Against
Againstthe
theRule
Rule
IOL Cylinder Power
3.5
3.5D+D+LRIs
LRIs
Expected Cylinder Correction from IOL2
1.5 D
1 1
2.0 D to 2.5 D
3.5 D
2.25 D
• Spherrical power: visit staartoric.com to calculate IOL powers and lens orientation
Corneal
CornealAstigmatism
Astigmatism
2.75 D or more
IOL
IOLCylinder
CylinderPower
Power
3.5 D+ LRIs
2 2
Expected
ExpectedCylinder
CylinderCorrection
Correctionfrom
fromIOL
IOL
2.25 D
1.25
1.25DDtoto1.75
1.75DD3
2.0
2.0DD
1.51.5DD
2.0
2.0DDtoto2.5
2.5DD
3.5
3.5DD
2.25
2.25DD
3.5
3.5D+D+LRIs
LRIs
2.25
2.25DD
nomogram assumes astigmatically neutral
surgery.
1
With the Rule,
steepastigmatically
corneal meridian
between
46 to 134; Against the Rule, steep corneal
nomogram
nomogram
assumes
assumes
astigmatically
neutral
neutral
surgery.
surgery.
With
Withthe
theRule,
Rule,steep
steepcorneal
cornealmeridian
meridianbetween
between4646toto134;
134;Against
Againstthe
theRule,
Rule,steep
steepcorneal
corneal
meridian between
between0 00toto
to4545
45and
and 135
135toto
to180.
180.
meridian
meridianbetween
and135
180.
power
selected
according
to corneal
astigmatism nomogram as follows:
2Cylinder
Approximate
Approximate
value
equivalent
cylinder
power
cornea.
Approximatevalue
valueofofofthethe
theequivalent
equivalentIOLIOL
IOLcylinder
cylinderpower
poweratatatthethe
thecornea.
cornea.
Combine
Combinewith
withAstigmatic
Astigmatickeratotomy
keratotomyororLimbal
LimbalRelaxing
RelaxingIncisions.
Incisions.
3
Combine with Astigmatic keratotomy or Limbal Relaxing Incisions.
2.75
2.75DDorormore
more
3 3
1 1
2 2
3 3
Available
Availableinina arange
rangeofofspherical
sphericalpowers
powerswith
withcylindrical
cylindricaladds
addsofof2.0
2.0DDand
and3.5
3.5DD
With the Rule
Available
in a range of spherical powers with cylindrical adds of 2.0 D and 3.5 D
1 plane,
• •AtAtthe
thecorneal
corneal
plane,the
theoptics
opticsofofthe
the2.0
2.0DDand
and3.5
3.5DDlenses
lensescorrect
correct
1.4
1.4DDand
and2.3
2.3DDofofastigmatism,
astigmatism,respectively
respectively
•Corneal
At theAstigmatism
corneal plane, the optics
of the Power
2.0 D and 3.5 D lenses
IOL Cylinder
Expectedcorrect
Cylinder Correction from IOL2
1.4 D and 2.3 D of astigmatism, respectively
1.5 D to 2.25 D
2.0 D
1.5 D
2.5 D to 3.0 D
3.5 D
2.25 D
3.25 D or more3
3.5 D+ LRIs
2.25 D
Stable. Predictable. Precise.
10.8
AA4203TF
noitatneiro snel dna srewop LOI etaluclac ot moc.cirotraats tisiv :rewop lacirrehpS •
Optic Characteristics
Diopter
Powers
Cylinder
naidireM laenroC 24
peDetotS28.5
otDLO
I cDiIncrements)
roT noitisoP
(0.5
2.0 D and 3.5 D
º09
º59
Shape
6.0mm Biconvex
Material
Silicone
Refractive index
1.41
:swollof sa margomon msitamgBiometry
itsa laenroc ot gnidrocca detceles rewop rednilyC
º081
ACD
º09 º59
2
naidireM laenroC 118.5
pee(Suggested)
tS ot LOI ciroT noitisoP
A-Constant
º0
LOI morf noitcerroC rednilyC detcepxE
5.26
Haptic Characteristics
eluR eht htiW
1
Overall length
10.8 mm
Material
Silicone
1.15 Diameter
rewoP rednilyC LOOne-Piece
I
msitamgForamina
itsA laenroC
Design
Style
Single Piece
noitatneiro snel dna srewop LOI etaluclac ot moc.cirotraats tisiv :rewop lacirrehpS •
D 5.1
11.2
D 52.2
AA4203TL
D 0.2
D 52.2 ot D 5.1
D 5.3
D 0.3 ot D 5.2
º0
º081
:swollof sa margomon msitamgitsa laenroc ot gnidrocca detceles rewop rednilyC
Optic Characteristics
D 52.2
sIRL +D 5.3Diopter
Powers
Shape
2
2
LOI morf noitcerroC rednilyC detcepxE
Material
Silicone
rewoP rednilyC LOI
Refractive index
D 5.1 Biometry
2
D 52.2
1.41
D 0.2
rewoP rednilyC LOI
D 52.2 A-Constant
D 5.1
erom ro D 52.3 Cylinder
D 52.2 ot D 5.1
msitamgitsA laenroC
D 0.3 ot D 5.2
5.26
D 0.2
Der5o7m.1root DD 5522..31
sIRL +D 5.3
Haptic Characteristics
Overall length
Material
eluR eht tsniagA
1
msitamgitsA laenroC
D 5.3118.5 (Suggested)
ACD
11.2 mm
D 5.3Silicone
2 D and 3.5 D
eluR eht htiW
1
6.0mm Biconvex
LOI morf noitcerroC rednilyC detcepxE
D 52.2
3
9.5 D to 23.5 D (0.5 D Increments)
3
1
eluR eht tsniagA
D 5.2 ot D 0.2
noitatneiro snel dna srewop LOI etaluclac ot moc.cirotraats tisiv :rewop lacirrehpS •
LOI morf noitcerroC rednilyC detcepxE
D D525..21
Design
rewoP rednilyC LOI
sIRL +DD 05..23Single Piece
Style
D 52.2
References
msitamgitsA laenroC
One-Piece 1.15 Diameter Foramina
erom ro D 57.2
3D 57.1 ot D 52.1
D 5.3
D 52.2
D 5.2 ot D 0.2
.ysrIeRgLru+sDla5rt.u3en yllacitamgitsa semeurosm
sa rmoaDrgo5m7.o2n
laenroc peets ,eluRFor
eht tsniamore
gA ;431 otinformation,
64 neewteb naidirem laenplease
roc peets ,eluvisit
R eht htiWwww.staar.com
or call STAAR Customer
800-352-7842.
..008811 oott 553311 ddnnaa 5544 ooService
tt 00 nneeeewwtteebb nnaaiiddat
iirreem
m
2. Data on File, STAAR Surgical.
:
s
w
o
l
l
o
f
s
a
m
a
r
g
o
m
o
n
m
s
i
t
a
m
g
i
t
s
a
l
a
e
n
r
o
c
o
t
g
n
i
d
r
o
c
c
a
d
e
t
c
e
l
e
s
r
e
w
o
p
r
e
d
n
i
l
y
C
2
..a
3. Apple DJ, Werner L. experts share insights
aeennrroocc eehhtt ttaa rreewwoopp rreeddnniillyycc LLOOII ttnneellaavviiuuqqee eehhtt ffoo eeuullaavv eettaam
miixxoorrppppAA
on IOL choice ; The best design is yet to
.snoisicnI gnixaleR labmiL ro ywww.staar.com
mototarek citamgitsA htiw enibmoC
come, Ocular Surgery News. 2002.
.snoisicnI gnixaleR labmiL ro ymototarek citamgitsA htiw enibmoC3
3
1. martin RG, Sanders DR. A comparison of
higher order aberrations following implanta1
.yregrus lartuen yllacitamgitsa semussa margomon
tion of four foldable intraocular lens designs.
laenroc peets ,eluR eht tsniagA ;431 ot 64 neewteb naidirem laenroc peets ,eluR eht htiW1
J Refract Surg. 2005;21:716-721.
2
3
4. Alio, J. L., et al. (2013) Clinical and optical
5.3 dna D 0.2 fo sdda lacirdnilyc htiw
intraocular performance ofD
rotationally
asymmetric multifocal IOL plate-haptic
design versus C-loop haptic design; Journal
tcerroc sesnel D 5.3 dna D 0.2
of Refractive Surgery. 29(4); 252-59.
srewop lacirehps fo egnar a ni elbaliavA
D 5.3 dna D 0.2 fo sdda lacirdnilyc htiw serhetwfoopsclaitcpioreehhpts,efonaelgpnlaare1anelrunoRiceeelbhhtathlitatAivWA•
ylevitcepser ,msitamgitsa fo D 3.2 dna D 4.1
Previze® is a registered trademark of Previze.
LOI morf noitcerroC retdcneilyrrCodcestceespnxEel D 5.3 dna Drew0o.2P erehdtnfiolyCsLcOitpI o eht ,enalmpsliataemngriotscAelahetntrAoC•
ylevitcepser ,msitamgitsa fo D 3.2 dna D 4.1
D 5.1
D 0.2
D 52.2 ot D 5.1
©2013 STAAR
2 Surgical Company
10-0007-52 A
Latvijas
LatvijasAmerikas
Amerikasacu
acucentrs
centrs••A.A.Deglava
Deglavaiela
iela12A,
12A,Rīga,
Rīga,LV-1009,
LV-1009,Latvija
Latvija
D 52.2
D 5.3
D 0.3 ot D 5.2
D 52.2
sIRL +D 5.3
erom ro D 52.3
Tirdzniecības
Tirdzniecībasun
uniepirkuma
iepirkumadirektors,
direktors,Rolands
RolandsLārmanis
Lārmanis
T:T:(+371)
(+371)67272257
67272257••GSM:
GSM:(+371)
(+371)29210121
29210121••Fakss:
Fakss:(+371)
(+371)67272128
67272128
E-pasts:
E-pasts:[email protected]
[email protected]••www.laac.lv
www.laac.lv
3